Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 241,000 | 236,000 |
| Accounts receivable | -125,000 | 12,000 |
| Other Working Capital | -84,000 | -44,000 |
| Other Operating Activity | 1,167,000 | 624,000 |
| Operating Cash Flow | $1,199,000 | $828,000 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 81,000 | N/A |
| Purchase Of Investment | -93,000 | N/A |
| Other Investing Activity | -377,000 | 962,000 |
| Investing Cash Flow | $-389,000 | $962,000 |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | -21,000 | -45,000 |
| Debt Issued | 0 | 17,000 |
| Debt Repayment | -29,000 | -31,000 |
| Common Stock Issued | 3,000 | 6,000 |
| Dividend Paid | -241,000 | -178,000 |
| Other Financing Activity | -183,000 | -7,000 |
| Financing Cash Flow | $-471,000 | $-238,000 |
| Exchange Rate Effect | 1,000 | 13,000 |
| Beginning Cash Position | 2,240,000 | 791,000 |
| End Cash Position | 2,580,000 | 2,356,000 |
| Net Cash Flow | $339,000 | $1,552,000 |
| Free Cash Flow | ||
| Operating Cash Flow | 1,199,000 | 828,000 |
| Capital Expenditure | -372,000 | -414,000 |
| Free Cash Flow | 827,000 | 414,000 |